News

Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster semaglutide-based weight‑loss injection—to Hims & Hers' digital storefront. The ...
Hims & Hers Health, Inc. (HIMS) Alleged“Deceptive” Marketing Of Wegovy® Triggers Securities Class Actions HIMS Investors With Losses Encouraged To Contact Hagens Berman
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
Drugmaker-telehealth deals risk unnecessary prescribing, senators’ probe finds
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Zacks Investment Research on MSN22h
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...